Chief of the Division of Plastic Surgery, Columbia University
| Role | Organisation | Sources |
|---|---|---|
| Chief of the Division of Plastic Surgery (former) | Columbia University | GBS Ventures (26 Sep 2016), GBS Ventures (20 Oct 2015) |
| Principal Investigator (former) | AirXpanders | GBS Ventures (22 Dec 2016), GBS Ventures (26 Sep 2016) |
Stories naming Dr Jeffrey Ascherman. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
Breast reconstruction device maker AirXpanders gained US regulator clearance for its needle-free AeroForm tissue expander, enabling a January 2017 American launch; an amended CE Mark also covers an enhanced version.
AirXpanders shared new clinical data for its AeroForm breast reconstruction device at a major plastic surgery meeting, showing faster expansion times, and an Australian study author received a best-paper award.
AirXpanders reported positive results from its XPAND pivotal trial of the AeroForm tissue expander at a major plastic surgery meeting, showing faster expansion than saline devices, as it seeks US FDA clearance.
AirXpanders' needle-free breast-reconstruction device is showcased at a major American plastic surgery conference, with trial results presented; the ASX-listed company awaits a US regulatory decision.
Also GBS Ventures·GBS Ventures
ASX-listed breast reconstruction device maker AirXpanders reports its pivotal XPAND trial met its primary endpoint, with results to go to the US regulator and be presented at a plastic surgery meeting in Boston.